logo
Share SHARE
FONT-SIZE Plus   Neg

Spectrum Pharma Q4 Profit Up - Quick Facts

Spectrum Pharmaceuticals, Inc. (SPPI) reported fourth-quarter profit of $8.28 million or $0.13 per share versus $4.44 million or $0.08 per share last year.

Adjusted earnings per share were up to $0.24 from $0.19 in the same quarter last year.

On average, five analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share. Analysts' estimates typically exclude special items.

Total revenues grew to $52.98 million from $33.95 million in the prior-year quarter. Analysts estimated revenues of $52.73 million.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology. While reporting a wider loss for the first quarter, Sears Holdings Corp. said it has decided to "aggressively evaluate" all potential alternatives for its top brands - Kenmore, Craftsman and DieHard or KCD, and the Sears Home Services or SHS businesses. Sears has retained Citigroup Global Markets and LionTree Advisors to assist in its efforts.
comments powered by Disqus
Follow RTT